Equities

Burning Rock Biotech Ltd

BNR:NMQ

Burning Rock Biotech Ltd

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)26.05
  • Today's Change1.04 / 4.16%
  • Shares traded118.75k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 24 2020 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • BNR:NMQ price rises above 50-day moving average to 26.49 at 13:24 GMT
  • BNR:NMQ price moved over +2.04% to 26.46
  • BNR:NMQ trading volume exceeds daily average by +19.31%
  • BNR:NMQ price rises above 50-day moving average to 26.46 at 09:30 GMT

Key statistics

On Tuesday, Burning Rock Biotech Ltd (BNR:NMQ) closed at 26.05, -19.60% below its 52-week high of 32.40, set on Jun 24, 2020.
52-week range
Today
18.64Sep 10 202032.40Jun 24 2020
Open24.71
High26.49
Low24.71
Bid24.83
Offer26.66
Previous close25.01
Average volume150.12k
Shares outstanding101.78m
Free float13.50m
P/E (TTM)--
Market cap2.64bn USD
EPS (TTM)-0.518
USD
Data delayed at least 15 minutes, as of Nov 24 2020 21:00 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.